Abraham Ceesay
CIK: 0001722140
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (50 total)
- Oct 21, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $29.16$64K - Oct 7, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $30.66$35K - Oct 6, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct3.4K shares at avg. $32.03$108K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct2K shares at avg. $39.05$76K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct215 shares at avg. $39.86$9K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct43 shares at avg. $41.05$2K - Sep 8, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $46.01$49K - Sep 8, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct7.1K shares at avg. $45.55$325K - Aug 25, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct18.9K shares at avg. $49.57$938K - Aug 11, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct19.5K shares at avg. $48.04$937K - Aug 11, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct5.8K shares at avg. $48.62$282K - Aug 11, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct3.7K shares at avg. $46.90$172K - Aug 10, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct14.2K shares at avg. $45.97$651K - Aug 10, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct8.4K shares at avg. $46.75$391K - Jul 27, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct7 shares at avg. $42.73$299.145 - Jul 27, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $42.11$93K - Jul 14, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $40.57$111K - Jul 14, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct5.5K shares at avg. $39.72$218K - Jun 29, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct7.3K shares at avg. $39.77$292K - Jun 29, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct876 shares at avg. $40.34$35K - May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct1.4K shares at avg. $177.62$255K - Feb 18, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct3.6K shares at avg. $29.05$103K - Feb 18, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Indirect2.1K shares at avg. $29.80$63K - Feb 18, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Indirect3K shares at avg. $29.04$87K - Feb 18, 2026RAPP
Rapport Therapeutics, Inc.
Sale(S)Direct2.3K shares at avg. $29.80$68K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 |  RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,210 | $29.16 | $64,448 | Direct |
| Oct 7, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 1,147 | $30.66 | $35,167 | Direct |
| Oct 6, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 3,375 | $32.03 | $108,106 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 1,952 | $39.05 | $76,230 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 215 | $39.86 | $8,570 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 43 | $41.05 | $1,765 | Direct |
| Sep 8, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 1,069 | $46.01 | $49,190 | Direct |
| Sep 8, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 7,141 | $45.55 | $325,308 | Direct |
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 18,921 | $49.57 | $937,957 | Direct |
| Aug 11, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 19,500 | $48.04 | $936,846 | Direct |
| Aug 11, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 5,794 | $48.62 | $281,721 | Direct |
| Aug 11, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 3,664 | $46.90 | $171,837 | Direct |
| Aug 10, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 14,171 | $45.97 | $651,492 | Direct |
| Aug 10, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 8,370 | $46.75 | $391,280 | Direct |
| Jul 27, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 7 | $42.73 | $299 | Direct |
| Jul 27, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,203 | $42.11 | $92,762 | Direct |
| Jul 14, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,729 | $40.57 | $110,722 | Direct |
| Jul 14, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 5,481 | $39.72 | $217,715 | Direct |
| Jun 29, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 7,344 | $39.77 | $292,062 | Direct |
| Jun 29, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 876 | $40.34 | $35,336 | Direct |
| May 8, 2026 |  CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 1,438 | $177.62 | $255,418 | Direct |
| Feb 18, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 3,552 | $29.05 | $103,191 | Direct |
| Feb 18, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,100 | $29.80 | $62,573 | Indirect |
| Feb 18, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,983 | $29.04 | $86,639 | Indirect |
| Feb 18, 2026 | RAPP Rapport Therapeutics, Inc. | Sale(S) | 2,281 | $29.80 | $67,970 | Direct |
1-25 of 50 transactions
About Ceesay Abraham
Ceesay Abraham (SEC CIK 0001722140) files insider reports with the SEC as Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) and Director of Pacira BioSciences, Inc. (PCRX).
Signal8 holds 22 ownership filings by Ceesay Abraham (1 Form 3, 21 Form 4), filed between Feb 4, 2025 and Oct 23, 2026. Those filings report 50 transactions, from Feb 3, 2025 to Oct 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ceesay Abraham's filings is in BOSTON, MA.
Recent filings by Ceesay Abraham
- Oct 21, 2026: Open-market sale of RAPP shares (Form 4, code S).
- Oct 7, 2026: Open-market sale of RAPP shares (Form 4, code S).
- Oct 6, 2026: Open-market sale of RAPP shares (Form 4, code S).
- Sep 23, 2026: Open-market sales of RAPP shares (3 lines, Form 4, code S).
- Sep 8, 2026: Open-market sales of RAPP shares (2 lines, Form 4, code S).
Other insiders filing for Rapport Therapeutics, Inc. (RAPP)
- HEALY JAMES, Director
- Sanchez Ramiro, Director
- Silva Paul M, Director
- Young Wendy B., Director
- PAUL STEVEN M, Director
- MARAGANORE JOHN, Director